JOIN NOW for exclusive pricing & express shipping

Contraceptives

This category supports clinical teams who stock and manage Contraceptives across care settings. Content reflects professional workflows, including documentation and receiving checks. Items are shipped from the US under standard carrier conditions. Use this hub to compare method classes and find supporting clinical references. Selection should follow local protocols and the official product label.

Navigation is organized by method type and common clinic use cases. Links below also point to condition-agnostic education for staff orientation. For implant background, review Nexplanon Implant Guide before building training materials.

Contraceptives Overview

Clinic formularies often include hormonal and non-hormonal options. Hormonal methods may be combined estrogen-progestin or progestin-only. Non-hormonal options rely on physical or chemical barriers. Some methods are user-controlled, while others are clinician-administered.

Longer-duration methods are often grouped as LARC (long-acting reversible contraception). These can reduce adherence burden, but they raise training needs. Injectable methods may involve DMPA (depot medroxyprogesterone acetate) processes. Facilities should align method access with staffing, scope, and follow-up capacity.

  • Hormonal contraception: systemic hormones delivered by pill, patch, ring, injection, or implant.
  • Non hormonal contraception: barrier methods, copper IUDs, and spermicides.
  • Emergency contraception: time-sensitive methods used after unprotected intercourse.
  • Barrier methods: condoms and diaphragms used at the time of sex.
  • Fertility awareness methods: cycle tracking approaches that require patient education.

Stock is brand-name and verified through documented supply channels.

What You’ll Find in This Category

This hub groups Contraceptives for browsing by administration route and clinic workflow. Product pages focus on identity, presentation, and handling notes. Educational pages support staff education and standardized counseling language. Content is designed for clinic operations, not patient self-selection.

When injectable contraception is in scope, start with the product record and supporting background. For a specific depot medroxyprogesterone presentation, see Depo Provera 150 mg Syringe. For staff onboarding, use What Is Depo Provera to align terminology. For longitudinal considerations, review Depo Provera Long Term Use during protocol updates.

  • Method class browsing for hormonal contraception and non hormonal contraception.
  • Context for LARC options, including implants and intrauterine approaches.
  • References for staff education on counseling language and expectations.
  • Related reading for implant workflows in Nexplanon Implant Guide.

Use the category listing to compare formats and pack presentations. Open each product page to confirm storage conditions and packaging details. Cross-check NDC or equivalent identifiers against receiving documents. Keep internal naming consistent across EHR, inventory, and billing systems.

How to Choose

Contraceptives selection usually combines patient factors with clinic operational constraints. Screening should align with the official label and local standing orders. Method fit also depends on follow-up access and staff competencies. Document the decision pathway to support quality review.

Clinical Fit

Use standardized intake to reduce missed contraindications and workflow drift. Consider whether a method includes estrogen exposure or is progestin-only. Confirm postpartum, breastfeeding, and thromboembolic risk considerations per protocol. For injectable counseling frameworks, reference What Is Depo Provera when building templates.

  • Patient preference for daily, pericoital, or long-duration administration.
  • Medical history flags that may affect method eligibility or monitoring needs.
  • Medication interactions that can reduce reliability for some hormonal methods.
  • Need for STI risk reduction, where barrier methods remain important.
  • Desire for reversibility and speed of return to fertility expectations.

Operational Considerations

Match method complexity to staff training and clinic throughput. Insertion and removal services require competency, supplies, and documentation. Injection workflows require sharps handling and scheduling support. Implant pathway overviews in Nexplanon Implant Guide can help standardize roles.

  • Visit length and rooming needs for procedures versus counseling-only visits.
  • Inventory controls, including lot tracking and expiration management.
  • Cold-chain or room-temperature storage requirements listed on labeling.
  • Consent, counseling, and adverse event documentation expectations.
  • Referral pathways for complications or difficult removals.

Safety and Use Notes

Contraceptives have method-specific contraindications, warnings, and counseling points. Clinics should rely on the official label for screening and administration details. Patient-specific selection should be guided by clinician assessment. Use consistent documentation to support follow-up and quality review.

For broad eligibility screening frameworks, see CDC U.S. Medical Eligibility Criteria for Contraceptive Use. These references can support protocol design and staff training. They do not replace product labeling or local policy requirements.

  • Combined hormonal methods may raise thrombotic risk in some patients.
  • Progestin-only methods can have different bleeding pattern expectations.
  • LARC placement requires training, aseptic technique, and complication triage plans.
  • Barrier methods can support STI risk reduction when used correctly.
  • Emergency options vary by mechanism and access pathway in practice.
  • Side effect discussions should distinguish expected effects from warning signs.

Why it matters: Standardized counseling language can reduce avoidable follow-up calls and chart ambiguity.

For regulatory context on nonprescription emergency options, review FDA consumer update on emergency contraception. Align counseling with local protocols and state scope requirements. Avoid extrapolating method comparisons beyond established references.

For staff-facing discussions about longer-term considerations with injectables, use Depo Provera Long Term Use as a starting framework. Confirm all specifics against the product label in use. Escalate concerns through established clinical oversight channels.

Clinic Ordering and Compliance Notes

Contraceptives in this catalog are supplied for professional use in clinical settings. Ordering is restricted to licensed clinics and healthcare professionals. Product availability and handling requirements vary by manufacturer labeling. Use your account profile to keep facility documentation current.

Receiving teams should verify identity, quantity, and packaging integrity on arrival. Record lot numbers and expiration dates in inventory systems when applicable. Store products per labeling, including light and temperature conditions. Route any discrepancies through internal incident workflows and supplier support.

  • Confirm facility credentials match the shipping and billing records.
  • Maintain traceability logs for lots used in administered products.
  • Use site product pages for presentation details, including Depo Provera 150 mg Syringe.
  • Align staff access to prescription products with scope and delegation rules.
  • Keep procedure checklists current for implants, injections, and device insertions.

Supplies come from screened distributors with traceable documentation.

Quick tip: Upload license documents once to reduce verification delays at checkout.

This content is for informational purposes only and is not a substitute for professional medical advice.

FILTERS

  • Price
  • Product categories
  • Brands
Depo-Provera®
Hormonal Contraceptive Injection
$52.79 - $59.99
Add to cart
Jaydess®
Hormonal Contraceptive
$354.63 - $402.99
Add to cart
Mirena® (English)
Intrauterine Device (Iud)
$350.23 - $397.99
Add to cart
Nexplanon®
Contraceptive Implant
$308.87 - $350.99
Add to cart
SMB® TCu 380A with Safeload
Contraceptive Implant
$240.23 - $272.99
Add to cart
T-Safe® CU 380A QL IUD
Intrauterine Device (Iud)
$294.79 - $334.99
Add to cart

Frequently Asked Questions